Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Critical Reagent Processing's ROE % for the quarter that ended in Mar. 2026 was -27.95%. Critical Reagent Processing's PB Ratio for the quarter that ended in Mar. 2026 was 0.78.
Critical Reagent Processing's ROE % Adjusted to Book Value for the quarter that ended in Mar. 2026 was -35.83%.
Critical Reagent Processing ROE % Adjusted to Book Value Related Terms
Critical Reagent Processing ROE % Adjusted to Book Value Historical Data
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Critical Reagent Processing ROE % Adjusted to Book Value Chart
FRA:DV4 vs NEM, AU: ROE % Adjusted to Book Value Comparison
For the Gold subindustry, Critical Reagent Processing's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Critical Reagent Processing ROE % Adjusted to Book Value vs Metals & Mining Industry
For the Metals & Mining industry and Basic Materials sector, Critical Reagent Processing's ROE % Adjusted to Book Value distribution charts can be found below:
* The bar in red indicates where Critical Reagent Processing's ROE % Adjusted to Book Value falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
What does a ROE % Adjusted to Book Value of -35.83% mean?
Critical Reagent Processing (FRA:DV4) has a ROE % Adjusted to Book Value of -35.83% as of Mar. 2026. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Critical Reagent Processing and its competitors.
Is Critical Reagent Processing's ROE % Adjusted to Book Value too high?
Critical Reagent Processing's current ROE % Adjusted to Book Value is -35.83%. Overall, Critical Reagent Processing has a GF Score™ of 32/100, reflecting its overall financial health beyond just this single metric.
How does Critical Reagent Processing's ROE % Adjusted to Book Value compare to NEM and AU?
Critical Reagent Processing's ROE % Adjusted to Book Value of -35.83% can be compared against companies in the Metals & Mining industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good ROE % Adjusted to Book Value for a Metals & Mining company?
A good ROE % Adjusted to Book Value depends on the Metals & Mining industry context. However, ROE % Adjusted to Book Value should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high ROE % Adjusted to Book Value mean?
A high ROE % Adjusted to Book Value can signal that a stock is expensive relative to its fundamentals. Return on equity adjusted to book is the ratio of return on equity to price-book ratio. View historical data on Critical Reagent Processing and its competitors. Critical Reagent Processing's current ROE % Adjusted to Book Value is -35.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Critical Reagent Processing stock overvalued right now?
Critical Reagent Processing (FRA:DV4) has a current ROE % Adjusted to Book Value of -35.83%. The current ROE % Adjusted to Book Value is -35.83%. Critical Reagent Processing's overall GF Score™ is 32/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is ROE % Adjusted to Book Value calculated?
ROE % Adjusted to Book Value is calculated from a company's financial statements. For Critical Reagent Processing (FRA:DV4), the current ROE % Adjusted to Book Value is -35.83% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Critical Reagent Processing Corp is engaged in the acquisition and exploration of mineral properties in Canada. The company explores gold and sodium carbonate. The projects of the company include Laguna Santa Maria Project. The project is comprised of two mining concessions which total 500 hectares. It earns maximum revenue from Argentina.
32GF Score
Get the complete analysis for FRA:DV4
ROE % Adjusted to Book Value is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:DV4 has been successfully added to your 
